Balchem Corporation Profile Avatar - Palmy Investing

Balchem Corporation

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States an…
Chemicals - Specialty
US, New Hampton [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
30.51 30.59 29.47 28.85 28.89 26.63 30.43 32.69 31.78 31.73 32.84 31.82 30.43 29.76 32.75
Profit Margin
12.21 13.05 13.28 12.89 13.31 9.76 10.81 10.12 15.14 12.21 12.38 12.03 12.03 11.18 11.77
Operating Margin
18.53 19.51 19.26 19.26 19.46 15.17 17.01 16.42 16.35 16.74 15.93 15.80 15.96 15.41 19.31
EPS Growth
38.03 21.43 14.29 - - 11.03 13.25 12.28 -8.33 59.66 -13.17 1.64 6.05 13.31 10.40 2.74
Return on Assets (ROA)
14.26 14.56 14.27 12.80 11.91 6.13 6.78 5.90 9.35 8.01 6.89 7.26 8.01 6.49 6.68
Return on Equity (ROE)
18.20 17.75 16.71 14.65 13.54 13.48 12.88 10.74 14.60 11.36 10.71 10.22 10.96 11.23 10.30
Return on Invested Capital (ROIC)
17.22 17.17 16.46 14.46 13.34 7.77 8.47 7.65 11.84 10.09 8.51 8.89 9.90 8.27 10.30
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
4.58 2.15 0.52 1.10 1.03 38.61 33.76 29.57 22.72 15.90 21.72 14.23 9.25 27.37 19.31
Debt/Equity
5.85 2.62 0.61 1.26 1.17 84.84 64.16 53.83 35.50 22.56 33.76 20.03 12.65 47.38 29.77
Debt/EBITDA
-97.38 -123.41 -172.56 -203.56 -268.45 250.48 159.19 176.48 126.06 66.75 123.23 48.64 3.02 189.82 114.35
Debt/Capitalization
5.53 2.55 0.60 1.24 1.16 45.90 39.08 34.99 26.20 18.40 25.24 16.69 11.23 32.15 22.94
Interest Debt per Share USD
0.31 0.18 0.05 0.12 0.13 10.95 9.76 9.06 7.07 5.07 8.00 5.29 3.52 14.21 10.51
Debt Growth
-41.40 -27.55 -71.31 143.33 13.00 8,476.22 -10.53 -5.72 -21.94 -28.76 59.34 -34.20 -33.63 305.80 -25.02
Liquidity
Current Ratio
275.06 439.38 568.50 700.90 776.93 189.80 245.10 186.56 183.90 275.80 276.34 282.64 224.08 239.79 211.62
Quick Ratio
223.51 370.42 482.69 617.64 694.02 128.00 179.09 120.68 121.45 187.45 172.47 193.57 153.44 142.49 127.77
Cash Ratio
137.31 261.80 371.30 478.72 583.86 52.64 104.53 38.26 37.29 66.14 71.18 89.56 71.79 47.53 43.40
Operating Cash Flow Ratio
100 100 100 100 100 - - 100 100 100 100 100 100 100 - - 100
Turnover
Inventory Turnover
1,091.87 1,126.17 1,104.61 1,067.29 965.81 800.46 834.10 650.44 668.55 654.04 515.35 679.34 610.43 553.12 566.45
Receivables Turnover
752.82 795.85 847.64 739.05 856.07 752.11 913.44 664.49 652.00 646.62 688.87 716.44 680.55 716.20 736.28
Payables Turnover
1,401.99 1,814.80 1,786.10 1,547.03 1,934.26 1,631.12 2,613.51 1,145.18 1,426.25 1,300.50 1,160.11 2,020.67 988.30 1,154.72 1,117.75
Asset Turnover
116.84 111.57 107.42 99.31 89.47 62.86 62.70 58.32 61.72 65.59 55.70 60.35 66.62 58.01 56.76
Coverage
Interest Coverage
19,454.07 55,300.00 66,934.52 597,770.00 273,341.67 1,596.56 1,425.09 1,250.35 1,289.17 1,415.73 1,720.98 2,503.87 5,191.45 1,413.97 750.48
Asset Coverage
1,900 3,500 15,500 7,600 8,400 100 200 200 300 500 300 500 800 200 300
Cash Flow Coverage (CFGR)
558.46 794.26 3,184.54 1,567.50 1,436.47 25.67 34.90 38.37 50.52 76.09 49.58 90.71 144.70 31.16 58.56
EBITDA Coverage
19,400 65,100 78,200 694,100 317,900 2,100 2,000 1,800 1,800 2,000 2,400 3,600 7,100 1,900 900
Dividend Coverage
-1,300 -1,000 -800 -300 - - -600 -600 -500 -700 -500 -500 -500 -500 -500 -400
Time Interest Earned (TIE)
200 200 200 300 300 200 200 200 200 200 100 100 200 200 200
Market Prospects
Dividend Yield
0.31 0.33 0.37 1.09 - - 0.38 0.49 0.40 0.47 0.53 0.46 0.45 0.34 0.53 0.48
Earnings Yield
4.15 3.52 3.35 3.73 2.58 2.57 3.15 2.10 3.49 3.11 2.44 2.28 1.77 2.70 2.27
Price/Earnings (P/E)
2,408.23 2,841.23 2,988.30 2,683.68 3,875.13 3,891.17 3,172.06 4,761.52 2,865.27 3,216.47 4,099.34 4,380.98 5,651.64 3,710.69 4,400.16
Price/Book (P/B)
438.38 504.34 499.30 393.24 524.79 524.51 408.54 511.51 418.36 365.41 439.17 447.62 619.31 416.70 453.14
Price/Sales (P/S)
293.95 370.67 396.90 345.89 515.74 379.68 342.89 481.76 433.90 392.63 507.37 526.87 679.76 414.90 517.76
Price/Cash Flow (P/CF)
1,341.83 2,422.43 2,579.87 1,996.25 3,122.40 2,408.38 1,824.61 2,476.60 2,333.06 2,129.18 2,624.10 2,463.43 3,383.79 2,822.26 2,599.06
End of BCPC's Analysis
CIK: 9326 CUSIP: 057665200 ISIN: US0576652004 LEI: - UEI: -
Secondary Listings
BCPC has no secondary listings inside our databases.